drugset / Trial / NCT02979366
Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The CL1-64315-001 study is a phase I, international, multicentre, open-label, non-randomised, non-comparative study. This study is designed in two parts: one part for dose escalation, one part for dose expansion.
Timeline
- Start
- 2017-03-15
- Primary completion
- 2020-05-11
- Completion
- 2020-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MIK665 | Unknown | 50 mg | Intravenous |